{
    "eid": "2-s2.0-85003845809",
    "title": "Alveolar bone in human immunodeficiency virus infection: is it changed by long-term antiretroviral therapy?",
    "cover-date": "2017-04-01",
    "subject-areas": [
        {
            "$": "General Dentistry",
            "@code": "3500"
        }
    ],
    "keywords": [
        "Alveolar bone",
        "antiretroviral therapy",
        "bone mineral density",
        "HIV",
        "porosity"
    ],
    "authors": [
        "Wipawee Nittayananta"
    ],
    "citedby-count": 2,
    "ref-count": 33,
    "ref-list": [
        "The osteoblast: A sophisticated fibroblast under central surveillance",
        "Bone resorption by osteoclasts",
        "Bone quality - The material and structural basis of bone strength and fragility",
        "Bone loss in the HIV-infected patient: Evidence, clinical implications, and treatment strategies",
        "Osteoporosis and bone health in HIV",
        "Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review",
        "Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study",
        "Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202",
        "HIV and bone disease",
        "Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy",
        "Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients",
        "Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy",
        "Reduced bone mineral density in HIV-infected patients: Prevalence and associated factors",
        "Potential predictive factors of osteoporosis in HIV-positive subjects",
        "First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir",
        "Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV",
        "Essentials of Dental Radiography and Radiology",
        "A Language and Environment for Statistical Computing",
        "Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals",
        "BMD is reduced in HIV-infected men irrespective of treatment",
        "Osteopenia in HIV-infected men: Association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy",
        "Risk factors for decreased bone density and effects of HIV on bone in the elderly",
        "Bone mass and mineral metabolism in HIV+ postmenopausal women",
        "Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection",
        "Higher rates of bone loss in postmenopausal HIV-infected women: A longitudinal study",
        "Increasing clarity on bone loss associated with antiretroviral initiation",
        "Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen",
        "Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial",
        "Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: Data from a randomized trial",
        "HIV and bone mineral density",
        "Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: A randomized, 96-week trial",
        "Stable bone density in HAART-treated individuals with HIV: A meta-analysis",
        "Changes in the radiographic characteristics of the mandibular alveolar process in dentate women with varying bone mineral density: A 5-year prospective study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hatyai",
            "affilname": "Prince of Songkla University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Bangkok Hospital Medical Center",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Chulalongkorn University Dental School",
        "NIH/NIDCR"
    ]
}